Arent Fox
ATTORNEY BIO
W. David Wallace

W. David Wallace
November 11, 2011
  • Partner
  • Washington, DC
202.857.6140
david.wallace@arentfox.com

David Wallace is a partner in the firm’s Intellectual Property Group. He practices in all areas of intellectual property, with a focus on patent prosecution, counseling and litigation in pharmaceuticals, nutraceuticals, cosmetics, foods, organic, and inorganic chemistry, polymers, medical devices, and biotechnology. David has extensive experience in counseling and defending generic pharmaceutical companies with respect to Hatch-Waxman litigation.

Client Work

David advises clients in the life sciences on obtaining, enforcing, and designing around patents. This includes preparing and prosecuting patent applications, providing opinions relating to the infringement or validity of patents, licensing, and due diligence investigations of third-party intellectual property portfolios. David has specialized experience in advising generic pharmaceutical companies regarding strategies for filing Abbreviated New Drug Application, including the development of non-infringement and invalidity positions against patents listed by brand companies in the Food and Drug Administration’s Orange Book.

Previous Work

Prior to joining Arent Fox, David was a partner at a national intellectual property law firm.

Professional Activities

David is an active member of the American Bar Association and the American Intellectual Property Law Association.

Publications, Presentations and Recognitions

David is a frequent lecturer and author on topics such as prosecution tips and strategies, case law developments in the US Court of Appeals for the Federal Circuit, prosecution history estoppel, and interviewing strategies. He has also been a judge in the Sutherland Moot Court competition and a faculty member of the Practicing Law Institute.

His publications include:

  • “The Impact of the America Invents Act on Patent Applications Filed On or After March 16, 2013,” co-author, with Patricia Granados, January 17, 2013
  • US Chapter, International Pharmaceutical Law and Practice, co-editor, with Matthew Bender, rev. 2005-08
  • “Life After Festo: Guarding Against Copyists,” Intellectual Property Today, January 2001

David’s speaking engagements include:

  • “Enforcing Efficiently – Where to Litigate in the US and Europe,” American Intellectual Property Law Association Mid-Winter Meeting, moderator, January 30, 2010
  • “Recent FDA Decisions Regarding Forfeiture of 180-Day Exclusivity,” Generic Pharmaceutical Association (GPhA) Annual Meeting, February 23, 2009
  • “Prophesies, Predictions and Patents: How Much Data Is Required to Obtain a Patent in the United States,” Association of University Technology Managers Annual Meeting, February 14, 2009
  • “Strategies For Efficient Prosecution,” 2008
  • “Recent Federal Circuit Decisions,” 2006
  • “Patent Prosecution Tips,” 2005
  • “Strategies For Responding to Office Actions,” 2003-2004

Life Beyond the Law

David enjoys golf, tennis, basketball, reading, and spending time with his family.

Bar and Court Admissions

  • District of Columbia Bar
  • Virginia Bar
  • Ohio Bar
  • US Patent and Trademark Office

Education

Case Western Reserve University School of Law
, JD
  ( cum laude )
State University of New York at Buffalo
, MS
Cornell University
, BS
  ( Chemistry )

Practices

  • Intellectual Property

Industries

  • Life Sciences
  • Medical Devices

Areas of Focus

  • Food & Drug
  • Intellectual Property
  • Litigation
  • Patent
1050 Connecticut Avenue, NW
Washington, DC 20036-5339
T202.857.6000 F202.857.6395
1675 Broadway
New York, NY 10019-5820
T212.484.3900F212.484.3990
555 West Fifth Street, 48th Floor
Los Angeles, CA 90013-1065
T213.629.7400F213.629.7401
www.arentfox.com